Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Hydroxychloroquine for generalized vitiligo vulgaris
IRCT20201212049690N1Phase 3Completed
- Sponsor
- Islamic Azad University
- Start
- May 2019
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 3, open-label, single-arm trial of hydroxychloroquine in Vitiligo, sponsored by Islamic Azad University. Primary endpoints: Complications, Extent and intensity and 1 more. Started May 2019; status: completed.
02
Drugs
hydroxychloroquine
03
Conditions
Vitiligo
Beyond the preview
Go deeper on IRCT20201212049690N1.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on IRCT20201212049690N1.